190 related articles for article (PubMed ID: 36142673)
1. Interplay between Prostate Cancer and Adipose Microenvironment: A Complex and Flexible Scenario.
Cancel M; Pouillot W; Mahéo K; Fontaine A; Crottès D; Fromont G
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142673
[TBL] [Abstract][Full Text] [Related]
2. Variable effects of periprostatic adipose tissue on prostate cancer cells: Role of adipose tissue lipid composition and cancer cells related factors.
Cancel M; Crottes D; Bellanger D; Bruyère F; Mousset C; Pinault M; Mahéo K; Fromont G
Prostate; 2024 Mar; 84(4):358-367. PubMed ID: 38112233
[TBL] [Abstract][Full Text] [Related]
3. Epigenome-wide DNA methylation profiling of periprostatic adipose tissue in prostate cancer patients with excess adiposity-a pilot study.
Cheng Y; Monteiro C; Matos A; You J; Fraga A; Pereira C; Catalán V; Rodríguez A; Gómez-Ambrosi J; Frühbeck G; Ribeiro R; Hu P
Clin Epigenetics; 2018; 10():54. PubMed ID: 29692867
[TBL] [Abstract][Full Text] [Related]
4. Periprostatic Adipose Tissue: A New Perspective for Diagnosing and Treating Prostate Cancer.
Cao H; Wang Y; Zhang D; Liu B; Zhou H; Wang S
J Cancer; 2024; 15(1):204-217. PubMed ID: 38164282
[TBL] [Abstract][Full Text] [Related]
5. Periprostatic adipose tissue thromboinflammation triggers prostatic neoplasia in early metabolic impairment: Interruption by rivaroxaban.
AlZaim I; El-Nikhely N; Al-Saidi A; Mougharbil N; Darwiche N; Abou-Kheir W; El-Yazbi AF
Life Sci; 2023 Dec; 334():122225. PubMed ID: 38084675
[TBL] [Abstract][Full Text] [Related]
6. LRP10, PGK1 and RPLP0: Best Reference Genes in Periprostatic Adipose Tissue under Obesity and Prostate Cancer Conditions.
Pérez-Gómez JM; Porcel-Pastrana F; De La Luz-Borrero M; Montero-Hidalgo AJ; Gómez-Gómez E; Herrera-Martínez AD; Guzmán-Ruiz R; Malagón MM; Gahete MD; Luque RM
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894825
[TBL] [Abstract][Full Text] [Related]
7. Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity.
Laurent V; Guérard A; Mazerolles C; Le Gonidec S; Toulet A; Nieto L; Zaidi F; Majed B; Garandeau D; Socrier Y; Golzio M; Cadoudal T; Chaoui K; Dray C; Monsarrat B; Schiltz O; Wang YY; Couderc B; Valet P; Malavaud B; Muller C
Nat Commun; 2016 Jan; 7():10230. PubMed ID: 26756352
[TBL] [Abstract][Full Text] [Related]
8. The Role of Periprostatic Adipose Tissue on Prostate Function in Vascular-Related Disorders.
Passos GR; Ghezzi AC; Antunes E; de Oliveira MG; Mónica FZ
Front Pharmacol; 2021; 12():626155. PubMed ID: 33643052
[TBL] [Abstract][Full Text] [Related]
9. Obesity and prostate cancer - microenvironmental roles of adipose tissue.
Saha A; Kolonin MG; DiGiovanni J
Nat Rev Urol; 2023 Oct; 20(10):579-596. PubMed ID: 37198266
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted Oncogenic Role of Adipocytes in the Tumour Microenvironment.
Jiramongkol Y; Lam EW
Adv Exp Med Biol; 2020; 1219():125-142. PubMed ID: 32130697
[TBL] [Abstract][Full Text] [Related]
11. Adipo-oncology: adipocyte-derived factors govern engraftment, survival, and progression of metastatic cancers.
Sato S
Cell Commun Signal; 2024 Jan; 22(1):52. PubMed ID: 38238841
[TBL] [Abstract][Full Text] [Related]
12. Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors.
Lengyel E; Makowski L; DiGiovanni J; Kolonin MG
Trends Cancer; 2018 May; 4(5):374-384. PubMed ID: 29709261
[TBL] [Abstract][Full Text] [Related]
13. Obesity and Cancer Metastasis: Molecular and Translational Perspectives.
Annett S; Moore G; Robson T
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33339340
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial Ca
De Mario A; Trevellin E; Piazza I; Vindigni V; Foletto M; Rizzuto R; Vettor R; Mammucari C
Sci Rep; 2024 Apr; 14(1):8469. PubMed ID: 38605098
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin: A player in the pathogenesis of hormone-dependent cancers.
Tsankof A; Tziomalos K
Front Endocrinol (Lausanne); 2022; 13():1018515. PubMed ID: 36277714
[TBL] [Abstract][Full Text] [Related]
16. Investigating periprostatic adipose tissue as a driving force of prostate cancer progression: a new source of information for the advancement of targeted therapy in metastatic prostate cancer.
La Civita E; Carbone G; Sicignano E; Crocetto F; Terracciano D
J Basic Clin Physiol Pharmacol; 2023 May; 34(3):245-247. PubMed ID: 36972321
[No Abstract] [Full Text] [Related]
17. "Adiponcosis interplay: adipose tissue, microenvironment and prostate cancer".
Di Zazzo E; Barone B; Crocetto F
J Basic Clin Physiol Pharmacol; 2024 May; ():. PubMed ID: 38797918
[No Abstract] [Full Text] [Related]
18. The role of adipose stroma in prostate cancer aggressiveness.
Kolonin MG; DiGiovanni J
Transl Androl Urol; 2019 Jul; 8(Suppl 3):S348-S350. PubMed ID: 31392166
[No Abstract] [Full Text] [Related]
19. Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches.
Lučić I; Kurtović M; Mlinarić M; Piteša N; Čipak Gašparović A; Sabol M; Milković L
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445860
[TBL] [Abstract][Full Text] [Related]
20. Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies.
Nadhan R; Kashyap S; Ha JH; Jayaraman M; Song YS; Isidoro C; Dhanasekaran DN
Metabolites; 2023 Apr; 13(5):. PubMed ID: 37233659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
